Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells.

Cheol Son J, Woo Kang D, Mo Yang K, Choi KY, Gen Son T, Min do S.

Exp Mol Med. 2013 Aug 30;45:e38. doi: 10.1038/emm.2013.75.

2.

Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells.

Natarajan V, Scribner WM, Morris AJ, Roy S, Vepa S, Yang J, Wadgaonkar R, Reddy SP, Garcia JG, Parinandi NL.

Am J Physiol Lung Cell Mol Physiol. 2001 Aug;281(2):L435-49.

3.

Involvement of stress activated protein kinases (JNK and p38) in 1,25 dihydroxyvitamin D3-induced breast cell death.

Brosseau CM, Pirianov G, Colston KW.

Steroids. 2010 Dec 12;75(13-14):1082-8. doi: 10.1016/j.steroids.2010.07.007. Epub 2010 Jul 21.

PMID:
20654640
4.

Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.

Kim MJ, Choi SY, Park IC, Hwang SG, Kim C, Choi YH, Kim H, Lee KH, Lee SJ.

Mol Cancer Res. 2008 Nov;6(11):1718-31. doi: 10.1158/1541-7786.MCR-08-0032.

7.

MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.

Yacoub A, Mitchell C, Hong Y, Gopalkrishnan RV, Su ZZ, Gupta P, Sauane M, Lebedeva IV, Curiel DT, Mahasreshti PJ, Rosenfeld MR, Broaddus WC, James CD, Grant S, Fisher PB, Dent P.

Cancer Biol Ther. 2004 Aug;3(8):739-51. Epub 2004 Aug 10.

PMID:
15197348
9.

β-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells.

Park MT, Song MJ, Lee H, Oh ET, Choi BH, Jeong SY, Choi EK, Park HJ.

PLoS One. 2011;6(10):e25976. doi: 10.1371/journal.pone.0025976. Epub 2011 Oct 6.

11.

The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines.

Miyata H, Sasaki T, Kuwahara K, Serikawa M, Chayama K.

Int J Oncol. 2006 Apr;28(4):915-21.

PMID:
16525641
13.

Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.

Kang DW, Park MH, Lee YJ, Kim HS, Lindsley CW, Alex Brown H, Min do S.

Int J Cancer. 2011 Feb 15;128(4):805-16. doi: 10.1002/ijc.25402.

14.

Participation of phospholipase D and alpha/beta-protein kinase C in growth factor-induced signalling in C3H10T1/2 fibroblasts.

Thorsen VA, Vorland M, Bjørndal B, Bruland O, Holmsen H, Lillehaug JR.

Biochim Biophys Acta. 2003 Jun 10;1632(1-3):62-71.

PMID:
12782152
15.

Low doses of ionizing radiation suppress doxorubicin-induced senescence-like phenotypes by activation of ERK1/2 and suppression of p38 kinase in MCF7 human breast cancer cells.

Shin JS, Woo SH, Lee HC, Hong SW, Yoo DH, Hong SI, Lee WJ, Lee MS, Jin YW, An S, Jin DH, Park IC.

Int J Oncol. 2010 Jun;36(6):1445-52.

PMID:
20428768
17.

Curcumin enhances the radiosensitivity of U87 cells by inducing DUSP-2 up-regulation.

Qian Y, Ma J, Guo X, Sun J, Yu Y, Cao B, Zhang L, Ding X, Huang J, Shao JF.

Cell Physiol Biochem. 2015;35(4):1381-93. doi: 10.1159/000373959. Epub 2015 Mar 12. Retraction in: Cell Physiol Biochem. 2016;39(2):814.

18.

Activation of ERK1/2 and p38 kinases by polycyclic aromatic hydrocarbons in rat liver epithelial cells is associated with induction of apoptosis.

Andrysík Z, Machala M, Chramostová K, Hofmanová J, Kozubík A, Vondrácek J.

Toxicol Appl Pharmacol. 2006 Mar 15;211(3):198-208. Epub 2005 Jul 11.

PMID:
16005925
19.

Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells.

Choi HJ, Han JS.

Biochim Biophys Acta. 2012 Jun;1823(6):1082-91. doi: 10.1016/j.bbamcr.2012.03.015. Epub 2012 Apr 5.

20.

Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells.

Kang DW, Lee JY, Oh DH, Park SY, Woo TM, Kim MK, Park MH, Jang YH, Min do S.

Exp Mol Med. 2009 Sep 30;41(9):678-85. doi: 10.3858/emm.2009.41.9.074.

Supplemental Content

Support Center